Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

NCT00370318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: 10 valent pneumococcal conjugate vaccine
BIOLOGICAL: Infanrix Hexa
BIOLOGICAL: Rotarix
DRUG: Paracetamol

Sponsor

GlaxoSmithKline